Document Type: Original Research


1 Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

2 Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Science. Tehran, Iran

4 Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences. Tehran, Iran


Background & Objective: Diabetic foot ulcer (DFU), is one of the most frequent causes for hospitalizations in patients with diabetes. A major problem in the treatment of DFU is the increased-incidence of methicillin-resistant Staphylococcus aureus (MRSA). The aim of this study was to determine the SCCmec types of MRSA isolates and their epidemiology among patients with diabetes.
Methods: This study was carried out on 145 diabetic patients with DFUs. The antibiotic susceptibility tests (ASTs) were performed using the disk diffusion method and E-test technique. SCCmec typing was done by multiplex PCR. Moreover, the presence of virulence toxin genes, including pvl and lukED was detected by PCR assay.
Results: In 145 samples from which S. aureus was predominantly isolated, 19.48% were MRSA. Analysis of MRSA isolates revealed that the most prevalent SCCmec type was type IV (46.7%) followed by type III (30.0%) and type V (20.0%). One strain (3.3%) was untypeable. The prevalence of pvl and lukED was 56.7% and 100%, respectively.
Conclusion: The high prevalence of MRSA in DFUs represents the high levels of antibiotic usage among patients with diabetes. In this study, resistance to other important clinical antibiotics was detected among MRSA isolates. The high proportion of SCCmec type IV and V strains, even in former hospitalized patients, indicates the entrance of these clones to the clinical setting.


Main Subjects

    1. Spichler A, Hurwitz BL, Armstrong DG, Lipsky BA. Microbiology of diabetic foot infections: from Louis Pasteur to 'crime scene investigation'. BMC medicine. 2015;13 (1):2. [DOI:10.1186/s12916-014-0232-0] [PMID] [PMCID]
    2. Mottola C, Semedo-Lemsaddek T, Mendes JJ, Melo-Cristino J, Tavares L, Cavaco-Silva P, Oliveira M. Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci. J Biomed Sci Eng. 2016;23 (1):33. [DOI:10.1186/s12929-016-0250-7] [PMID] [PMCID]
    3. Feng SH, Chu YJ, Wang PH, Jun X, Min D, Li XM. Risk factors and gene type for infections of MRSA in diabetic foot patients in Tianjin, China. Int J Low Extrem Wounds. 2013;12(2):106-12. [DOI:10.1177/1534734613489991] [PMID]
    4. Ito T, Kuwahara-Arai K, Katayama Y, Uehara Y, Han X, Kondo Y, Hiramatsu K. Staphylococcal Cassette Chromosome mec (SCCmec) analysis of MRSA. Methods in molecular biology (Clifton, NJ). 2014;1085:131-148. [DOI:10.1007/978-1-62703-664-1_8] [PMID]
    5. Ohadian Moghadam S, Pourmand MR, Mahmoudi M, Sadighian H, Molecular characterization of methicillin-resistant Staphylococcus aureus: characterization of major clones and emergence of epidemic clones of sequence type (ST) 36 and ST 121 in Tehran, Iran. FEMS Microbiol Lett. 2015;362(8):fnv043. [DOI:10.1093/femsle/fnv043] [PMID]
    6. Frykberg RG. Diabetic foot ulcers: pathogenesis and management. Am Fam Physician. 2002;66 (9):1655-62.
    7. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70(2):631-41. [DOI:10.1128/IAI.70.2.631-641.2002] [PMID] [PMCID]
    8. Havaei S, Moghadam SO, Pourmand MR, Faghri J. Prevalence of genes encoding bi-component leukocidins among clinical isolates of methicillin resistant Staphylococcus aureus. Iran J Public Health. 2010;39(1):8.
    9. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36 (2):131-9. [DOI:10.1086/345436] [PMID]
    10. Demling RH, Waterhouse B. The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds. 2007;7: e8.
    11. Otter J, French. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect. 2011;79(3):189-93. [DOI:10.1016/j.jhin.2011.04.028] [PMID]
    12. Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, Melo-Cristino J. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95(1):153-61. [DOI:10.1016/j.diabres.2011.10.001] [PMID]
    13. Akhi MT, Ghotaslou R, Asgharzadeh M, Varshochi M, Pirzadeh T, Memar MY, Bialvaei AZ, Sofla HSY, Alizadeh N. Bacterial etiology and antibiotic susceptibility pattern of diabetic foot infections in Tabriz, Iran. GMS Hyg Infect Control. 2015;10;02.
    14. Anvarinejad M, Pouladfar G, Japoni A, Bolandparvaz S, Satiary Z, Abbasi P, Mardaneh J. Isolation and antibiotic susceptibility of the microorganisms isolated from diabetic foot infections in Nemazee hospital, Southern Iran. 2015;J Pathog 2015: 328796. [DOI:10.1155/2015/328796] [PMID] [PMCID]
    15. Dang C, Prasad Y, Boulton A, Jude E. Methicillin‐resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003;20 (2):159-61. [DOI:10.1046/j.1464-5491.2003.00860.x] [PMID]
    16. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, Asgari F, Mousavizadeh M, Rafei A, Khajeh E. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract. 2014;103(2):319-27. [DOI:10.1016/j.diabres.2013.12.034] [PMID]
    17. Shettigar K, Jain S, Bhat DV, Acharya R, Ramachandra L, Satyamoorthy K, Murali TS. Virulence determinants in clinical Staphylococcus aureus from monomicrobial and polymicrobial infections of diabetic foot ulcers. J Med Microbiol. 2016;65(12):1392-404. [DOI:10.1099/jmm.0.000370] [PMID]
    18. Reveles KR, Duhon BM, Moore RJ, Hand EO, Howell CK. Epidemiology of methicillin-resistant Staphylococcus aureus diabetic foot infections in a large academic hospital: implications for antimicrobial stewardship. PloS one. 2016;11(8):e0161658. [DOI:10.1371/journal.pone.0161658] [PMID] [PMCID]
    19. Ertugrul B, Oncul O, Tulek N, Willke A, Sacar S, Tunccan O, Yilmaz E, Kaya O, Ozturk B, Turhan O. A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis. 2012;31(9):2345-52. [DOI:10.1007/s10096-012-1574-1] [PMID]
    20. Richard JL, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, Lavigne JP. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. J Diabetes Metab. 2008;34(4):363-9. [DOI:10.1016/j.diabet.2008.02.005] [PMID]
    21. Nather A, Bee CS, Huak CY, Chew JL, Lin CB, Neo S, Sim EY. Epidemiology of diabetic foot problems and predictive factors for limb loss. Journal of diabetes and its complications. 2008;22(2):77-82. [DOI:10.1016/j.jdiacomp.2007.04.004] [PMID]
    22. Dow G. Bacterial swabs and the chronic wound: when, how, and what do they mean? Ostomy Wound Manage. 2003;49 (5A Suppl):8-13
    23. Ho P-L, Chuang S-K, Choi Y-F, Lee RA, Lit AC, Ng T-K, Que T-L, Shek K-C, Tong H-K, Cindy W. Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong. Diagn Microbiol Infect Dis. 2008;61(3):245-50. [DOI:10.1016/j.diagmicrobio.2007.12.015] [PMID]
    24. Moghadam SO, Yaghooti MM, Pourramezan N, Pourmand MR. Molecular characterization and antimicrobial susceptibility of the CA-MRSA isolated from healthcare workers, Tehran, Iran. Microb Pathog. 2017;107:409-12. [DOI:10.1016/j.micpath.2017.04.027] [PMID]
    25. Sotto A, Lina G, Richard J-L, Combescure C, Bourg G, Vidal L, Jourdan N, Etienne J, Lavigne JP. Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: a new paradigm. Diabetes Care. 2008;31(12):2318-24. [DOI:10.2337/dc08-1010] [PMID] [PMCID]